Bliss GVS Pharma Limited

NSEI:BLISSGVS Voorraadrapport

Marktkapitalisatie: ₹14.6b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Bliss GVS Pharma Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Gagan Sharma

Algemeen directeur

₹21.6m

Totale compensatie

Percentage CEO-salaris100.0%
Dienstverband CEO3.4yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn3.4yrs
Gemiddelde ambtstermijn bestuur6.5yrs

Recente managementupdates

Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now

Jul 19
Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now

Recent updates

These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely

Aug 25
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely

Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares

Aug 07
Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares

Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now

Jul 19
Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now

Bliss GVS Pharma's (NSE:BLISSGVS) Dividend Will Be ₹0.50

Jul 18
Bliss GVS Pharma's (NSE:BLISSGVS) Dividend Will Be ₹0.50

Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

Jul 04
Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated

May 10
We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated

Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking

Apr 27
Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking

Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

Feb 20
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding

Jan 26
There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding

Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

Jul 14
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?

Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50

Sep 11
Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50

Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

Aug 28
Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50

These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well

May 21
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well

Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)

Apr 08
Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)

A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns

Mar 18
A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns

Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend

Feb 25
Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend

Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet

Feb 08
Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet

What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?

Jan 21
What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?

Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?

Jan 08
Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?

How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?

Dec 26
How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?

Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?

Dec 13
Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?

Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?

Nov 30
Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?

Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings

Nov 18
Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings

Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?

Nov 06
Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?

Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?

Oct 25
Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?

Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Oct 07
Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?

Sep 19
How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?

Analyse CEO-vergoeding

Hoe is Gagan Sharma's beloning veranderd ten opzichte van Bliss GVS Pharma's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

₹815m

Mar 31 2024₹22m₹22m

₹755m

Dec 31 2023n/an/a

₹879m

Sep 30 2023n/an/a

₹883m

Jun 30 2023n/an/a

₹598m

Mar 31 2023₹18m₹18m

₹709m

Dec 31 2022n/an/a

₹871m

Sep 30 2022n/an/a

₹91m

Jun 30 2022n/an/a

₹165m

Mar 31 2022₹15m₹15m

₹150m

Dec 31 2021n/an/a

₹17m

Sep 30 2021n/an/a

₹773m

Jun 30 2021n/an/a

₹766m

Mar 31 2021₹1m₹1m

₹685m

Compensatie versus markt: De totale vergoeding ($USD 258.16K ) Gagan } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 184.73K ).

Compensatie versus inkomsten: De vergoeding van Gagan is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.


CEO

Gagan Sharma (41 yo)

3.4yrs

Tenure

₹21,639,379

Compensatie

Mr. Gagan Harsh Sharma serves as Managing Director at Bliss GVS Pharma Limited since May 11, 2021 and its Director since January 21, 2021. He served as Vice President of Strategy and Business Development a...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Gagan Sharma
MD & Director3.4yrs₹21.64mgeen gegevens
Deepak Sawant
Chief Financial Officer1.8yrs₹6.48mgeen gegevens
Aditi Bhatt
Compliance Officer6.2yrs₹1.84mgeen gegevens
Shruti Vishal Rao
Executive & Whole Time Directorno data₹7.41m2.01%
₹ 292.9m
Prashant Churi
Vice President of Technical Operationsno datageen gegevensgeen gegevens
Vibha Sharma
Executive & Whole Time Directorno data₹7.05m2.35%
₹ 343.5m
Sourya Das
Associate Vice Presidentno datageen gegevensgeen gegevens

3.4yrs

Gemiddelde duur

41yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van BLISSGVS wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.4 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Gagan Sharma
MD & Director3.8yrs₹21.64mgeen gegevens
Shruti Vishal Rao
Executive & Whole Time Director18.3yrs₹7.41m2.01%
₹ 292.9m
Vibha Sharma
Executive & Whole Time Director16.3yrs₹7.05m2.35%
₹ 343.5m
Shilpa Bhatia
Independent Women Director4.7yrs₹375.00kgeen gegevens
Santosh Parab
Independent Non-Executive Director8.4yrs₹375.00kgeen gegevens
Nandkumar Chodankar
Additional Independent Directorless than a yeargeen gegevensgeen gegevens

6.5yrs

Gemiddelde duur

45.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van BLISSGVS wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.5 jaar).